Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Development of 3D Printed Multi-Layered Orodispersible Films with Porous Structure Applicable as a Substrate for Inkjet Printing

J. Elbl, M. Veselý, D. Blaháčková, J. Ondruš, P. Kulich, E. Mašková, J. Mašek, J. Gajdziok

. 2023 ; 15 (2) : . [pub] 20230220

Status not-indexed Language English Country Switzerland

Document type Journal Article

The direct tailoring of the size, composition, or number of layers belongs to the advantages of 3D printing employment in producing orodispersible films (ODFs) compared to the frequently utilized solvent casting method. This study aimed to produce porous ODFs as a substrate for medicated ink deposited by a 2D printer. The innovative semi-solid extrusion 3D printing method was employed to produce multilayered ODFs, where the bottom layer assures the mechanical properties. In contrast, the top layer provides a porous structure for ink entrapment. Hydroxypropyl methylcellulose and polyvinyl alcohol were utilized as film-forming polymers, glycerol as a plasticizer, and sodium starch glycolate as a disintegrant in the bottom matrix. Several porogen agents (Aeroperl® 300, Fujisil®, Syloid® 244 FP, Syloid® XDP 3050, Neusilin® S2, Neusilin® US2, and Neusilin® UFL2) acted as porosity enhancers in the two types of top layer. ODFs with satisfactory disintegration time were prepared. The correlation between the porogen content and the mechanical properties was proved. A porous ODF structure was detected in most samples and linked to the porogen content. SSE 3D printing represents a promising preparation method for the production of porous ODFs as substrates for subsequent drug deposition by 2D printing, avoiding the difficulties arising in casting or printing medicated ODFs directly.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002874
003      
CZ-PrNML
005      
20230421100027.0
007      
ta
008      
230413s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/pharmaceutics15020714 $2 doi
035    __
$a (PubMed)36840036
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Elbl, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic $1 https://orcid.org/0000000150535669
245    10
$a Development of 3D Printed Multi-Layered Orodispersible Films with Porous Structure Applicable as a Substrate for Inkjet Printing / $c J. Elbl, M. Veselý, D. Blaháčková, J. Ondruš, P. Kulich, E. Mašková, J. Mašek, J. Gajdziok
520    9_
$a The direct tailoring of the size, composition, or number of layers belongs to the advantages of 3D printing employment in producing orodispersible films (ODFs) compared to the frequently utilized solvent casting method. This study aimed to produce porous ODFs as a substrate for medicated ink deposited by a 2D printer. The innovative semi-solid extrusion 3D printing method was employed to produce multilayered ODFs, where the bottom layer assures the mechanical properties. In contrast, the top layer provides a porous structure for ink entrapment. Hydroxypropyl methylcellulose and polyvinyl alcohol were utilized as film-forming polymers, glycerol as a plasticizer, and sodium starch glycolate as a disintegrant in the bottom matrix. Several porogen agents (Aeroperl® 300, Fujisil®, Syloid® 244 FP, Syloid® XDP 3050, Neusilin® S2, Neusilin® US2, and Neusilin® UFL2) acted as porosity enhancers in the two types of top layer. ODFs with satisfactory disintegration time were prepared. The correlation between the porogen content and the mechanical properties was proved. A porous ODF structure was detected in most samples and linked to the porogen content. SSE 3D printing represents a promising preparation method for the production of porous ODFs as substrates for subsequent drug deposition by 2D printing, avoiding the difficulties arising in casting or printing medicated ODFs directly.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Veselý, Martin $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic $1 https://orcid.org/0000000203528084
700    1_
$a Blaháčková, Dagmar $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic
700    1_
$a Ondruš, Jaroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00 Brno, Czech Republic $1 https://orcid.org/0000000165026840
700    1_
$a Kulich, Pavel $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00 Brno, Czech Republic
700    1_
$a Mašková, Eliška $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00 Brno, Czech Republic $1 https://orcid.org/0000000208387401
700    1_
$a Mašek, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 70, 621 00 Brno, Czech Republic
700    1_
$a Gajdziok, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University Brno, Palackého tř. 1946/1, 612 42 Brno, Czech Republic $1 https://orcid.org/0000000155995648
773    0_
$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 15, č. 2 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36840036 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421100020 $b ABA008
999    __
$a ok $b bmc $g 1922694 $s 1189081
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 2 $e 20230220 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
LZP    __
$a Pubmed-20230413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...